课题基金 / 基金详情

Development of array based comparative genomic hybridization (CGH) as a diagnostic tool for cryptic chromosome aberrations in congenital disorders

Development of array based comparative genomic hybridization (CGH) as a diagnostic tool for cryptic chromosome aberrations in congenital disorders
开发基于阵列的比较基因组杂交(CGH)作为先天性疾病中隐性染色体畸变的诊断工具
批准号:
17390099
负责人:
INAZAWA Johji
金额:
$9.34万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2005
资助国家:
日本
项目状态:
已结题
起止时间:
2005 至 2006

项目摘要

项目成果

INAZAWA Johji的其他基金

相似基金

相关文献

中文摘要
翻译
人类基因组测序计划已经成功实施,99%的基因组测序准确率达到99.99%。在后测序时代,疾病相关基因组改变的检测与鉴定与多种先天性异常伴精神发育迟滞(MCA/MR)、自闭症和其他未知基因组疾病相关的基因直接相关。然而,我们没有任何工具来探索100 kb水平的隐性染色体畸变。为了克服这种情况,我们构建了如下高分辨率CGH阵列:(1)全基因组阵列(WGA)-4500,其包含贯穿整个基因组的4523个BAC,(2)癌症阵列-800,其包含不同癌症相关基因的800个BAC,(3)1 p36-contig阵列,其覆盖约20 Mb跨越1 p36区域,具有212个BAC,(4)染色体X-平铺阵列,其包含除了假常染色体区域之外的整个染色体X的1001个BAC,和(5)基因组病症(GD)-阵列,其用作已知基因组病症的诊断工具。使用这些内部BAC阵列,我们探讨了大量MCA/MR患者的隐性染色体畸变,并在其中一些患者中检测到与未知MCA/MR发病机制相关的从头亚显微畸变。
英文摘要
The human genome sequencing project had been conducted successfully, with 99% of the genome sequenced with 99.99% accuracy. In the post-sequence era, detection of disease-related genomic alterations is directly connected with identification of genes associated with multiple congenital anomalies with mental retardation (MCA/MR), autism, and other unknown genomic disorders. However, we had none of tools for exploring cryptic chromosome aberrations at 100kb-level. In order to overcome the situation, we have constructed high-resolution CGH-arrays as follows, (1) Whole Genome Array (WGA)-4500, which contains 4523 BACs throughout the whole genome, (2) Cancer Array-800, which harbors 800 BACs for different cancer-related genes, (3) 1p36-contig array, which covers about 20Mb spanning 1p36 region with 212 BACs, (4) Chromosome X-tiling array, which contains 1001 BACs throughout chromosome X except pseudo-autosomal region, and (5) Genome Disorder (GD)-array, which is employed as the diagnostic tool for known genomic disorders. Using those in-house BAC arrays, we explored cryptic chromosome aberrations in a large number of patients with MCA/MR, and detected de novo submicroscopic aberrations related to the pathogenesis of unknown MCA/MR in some of those patients.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1002/ajmg.a.31770
发表时间: 2007-06-15
期刊: AMERICAN JOURNAL OF MEDICAL GENETICS PART A
影响因子: 2
作者: [Tokutomi, Tomoharu, Hayashi, Shin, Nonoyama, Shigeaki]
通讯作者: Nonoyama, Shigeaki
DOI: --
发表时间: 2006
期刊: Annals of neurology
影响因子: 11.2
作者: [K. Nishioka;Shin Hayashi;M. Farrer;A. Singleton;H. Yoshino;H. Imai;Toshiaki Kitami;Kenichi Sato;R. Kuroda;H. Tomiyama;K. Mizoguchi;M. Murata;T. Toda;I. Imoto;J. Inazawa;Y. Mizuno;N. Hattori]
通讯作者: K. Nishioka;Shin Hayashi;M. Farrer;A. Singleton;H. Yoshino;H. Imai;Toshiaki Kitami;Kenichi Sato;R. Kuroda;H. Tomiyama;K. Mizoguchi;M. Murata;T. Toda;I. Imoto;J. Inazawa;Y. Mizuno;N. Hattori
Clinical and molecular cytogenetic characterization od two patients with non-mutational aberrations of the FMR2 gene.
两名 FMR2 基因非突变畸变患者的临床和分子细胞遗传学特征。
DOI: --
发表时间: 2007
期刊: Am J Med Genet.A 143
影响因子: --
作者: [Honda S, Inazawa J, et al.]
通讯作者: et al.
食道癌の検出方法
如何发现食道癌
DOI: --
发表时间: 2012
期刊:
影响因子: --
作者: []
通讯作者:
共 35 条
    Innovative development of DDS for microRNA therapeutics by an application of anti-PCSK9 antibody
    • 批准号:
      16K14630
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.41万
    • 财政年份:
      2016
    • 负责人:
      INAZAWA Johji
    • 依托单位:
    Chromothripsis-like pattern in cancer-cell genome after irradiation by a focused vertical micro-beam system, SPICE
    • 批准号:
      25640062
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.58万
    • 财政年份:
      2013
    • 负责人:
      INAZAWA Johji
    • 依托单位:
    Development of diagnostic tools for personalized cancer medicine by genomic and epigenomic analyses
    • 批准号:
      22240090
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $32.12万
    • 财政年份:
      2010
    • 负责人:
      INAZAWA Johji
    • 依托单位:
    Integrative genomics and epigenomics for personalized cancer medicine
    • 批准号:
      17015012
    • 项目类别:
      Grant-in-Aid for Scientific Research on Priority Areas
    • 资助金额:
      $74.56万
    • 财政年份:
      2005
    • 负责人:
      INAZAWA Johji
    • 依托单位:
    海外基金